SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-18-000375
Filing Date
2018-06-05
Accepted
2018-06-05 13:50:22
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERM. JAMES BARRETTNEA 12 GP, LLCNEA 15 GP, LLCNEA 15 OPPORTUNITY FUND, L.P.NEA PARTNERS 12, LIMITED PARTNERSHIPNEA PARTNERS 15, L.P.NEA PARTNERS 15-OF, L.P.NEW ENTERPRISE ASSOCIAT

Document Format Files

Seq Description Document Type Size
1 ARDELYX, INC. - SCHEDULE 13D/A - AMENDMENT #5 ardelyx-13da5_18219.htm SC 13D/A 613912
  Complete submission text file 0001072613-18-000375.txt   616097
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Filed by) CIK: 0001383391 (see all company filings)

IRS No.: 204670653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Subject) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88209 | Film No.: 18880667
SIC: 2834 Pharmaceutical Preparations